Osteoporosis: Trials and tribulations

American Journal of Medicine

Volumn 103, Issue 2 A, 1997, Pages

  Seeman, E ^a   Black, D ^a   Cooper, C ^a   Karpf, D B ^a   Slemenda, C ^a   Cummings, S ^a   Johnell, O ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; CALCITONIN; CALCITRIOL; CALCIUM; CLODRONIC ACID; ESTROGEN; ETIDRONIC ACID; FLUORIDE; FLUORIDE SODIUM; FLUOROPHOSPHATE; GESTAGEN; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; PLACEBO; PROSTAGLANDIN E2; SALCATONIN; SOMATOMEDIN C; TILUDRONIC ACID; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; VERTEBRA FRACTURE;

EID: 0030883779     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(97)90029-2     Document Type: Conference Paper

References (67)

1. T Storm G Thamsborg T Steiniche Effect of cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis N Engl J Med 322 1990 1265 1271
2. NB Watts ST Harris HK Genant Intermittent cyclical etidronate therapy of post-menopausal osteoporosis N Engl J Med 323 1990 73 79
3. UA Liberman SR Weiss J Broll Effects of three years treatment with oral alendronate on fracture incidence in women with postmenopausal osteoporosis N Engl J Med 333 1995 1437 1443
4. DM Black SR Cummings DB Karpf Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1996 1535 1541
5. EG Lufkin HW Wahner WM O'Fallon Treatment of postmenopausal osteoporosis with transdermal estrogen Ann Intern Med 117 1992 1 9
6. R Lindsay DM Hart C Forrest C Baird Prevention of spinal osteoporosis in oophorectomised women Lancet ii 1980 1151 1154
7. K Overgaard MA Hansen SB Jensen C Christiansen Effect of salcatonin given intra-nasally on bone mass and fracture rates in established osteoporosis: a dose-response study Br Med J 305 1992 556 561
8. MW Tilyard GFS Spears J Thomson S Dovey Treatment of postmenopausal osteoporosis with calcitriol or calcium N Engl J Med 326 1992 357 362
9. JC Gallagher BL Riggs RR Recker D Goldgar The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency Proc Soc Exp Biol Med 191 1989 287 292
10. 3 Bone Miner 3 1987 47 52
11. R Recker DB Kimmel S Hinders KM Davies Antifracture efficacy of calcium in elderly women J Bone Miner Res 9 suppl 1 1994 135
12. IR Reid RW Ames MC Evans Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women—a randomised controlled trial Am J Med 98 1995 331 335
13. BL Riggs SF Hodgson WM O'Fallon Effect of fluoride treatment on fracture rate in post-menopausal women with osteoporosis N Engl J Med 322 1990 802 809
14. M Kleerekoper EL Peterson DA Nelson A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis Osteoporos Int 1 1991 155 161
15. N Mamelle PJ Meunier R Dusan Risk-benefit ratio of sodium flouride treatment in primary vertebral osteoporosis Lancet ii 1988 3651 3655
16. CYC Pak K Sakhaee V Piziak Slow-release sodium flouride in the management of postmenopausal osteoporosis Ann Intern Med 120 1994 625 632
17. 3 and calcium to prevent hip fractures in elderly women N Engl J Med 327 1992 1637 1642
18. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and
19. RJ Heikinheimo JA Inkovaara EJ Harju Annual injection of vitamin D and fractures of aged bones Calcif Tissue Int 51 1992 105 110
20. JB Lauritzen MM Petersen B Lund Effect of external hip protectors on hip fractures Lancet 341 1993 11 13
21. AM Parfitt Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis Miner Electrolyte Metab 4 1980 273 287
22. RP Heaney The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change J Bone Miner Res 9 1994 1515 1523
23. CA Kraenzlin HG Haas ME Kraenzlin The effectiveness of estrogen-therapy to increase bone mineral density is dependent on the basal bone resorption rate (Abstr. B157.) J Bone Miner Res 9 suppl 1 1994 S269
24. R Civitelli S Gopnelli F Zacchei Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment J Clin Invest 82 1988 1268 1274
25. RW Boyce CL Paddock JR Gleason The effect of risedronate on canine cancellous bone remodelling: three dimensional kinetic reconstruction of the remodeling site J Bone Miner Res 10 1995 211 221
26. T Storm T Steiniche G Thamsborg F Melsen Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis J Bone Miner Res 8 1993 199 208
27. G Jones T Nguyen P Sambrook Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study Br Med J 309 1994 691 695
28. KE Ensrud L Palermo DM Black Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures J Bone Miner Res 10 1995 1778 1787
29. J Foldes AM Parfitt M-S Shin Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis J Bone Miner Res 6 1991 759 766
30. JA Cauley DG Seeley K Ensrud Estrogen replacement therapy and fractures in older women Ann Intern Med 122 1995 9 16
31. P Maxim B Ettinger GM Spitalny Fracture protection provided by longterm estrogen treatment Osteoporos Int 5 1995 23 29
32. JC Gallagher D Baylink Effect of estrone sulphate on bone mineral density of the femoral neck and spine (Abstract 802.) J Bone Miner Res 5 suppl 2 1990 S275
33. DT Felson Y Zhang MT Hannan The effect of postmenopausal estrogen therapy on bone density in elderly women N Engl J Med. 329 1993 1141 1146
34. C Christiansen BJ Riis 17β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elder women J Clin Endocrinol Metab 71 1990 836 884
35. CH Turner M Sto HU Bryant Raloxifene preserves bone strength and bone mass in ovarectomized rats Endocrinology 135 1994 2001 2005
36. ST Harris NB Watts RD Jackson Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy Am J Med 95 1993 557 567
37. P Filipponi M Pedetti L Fedeli Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy J Bone Miner Res 10 1995 697 703
38. SJ Wimalawansa Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study Am J Med 99 1995 36 42
39. B Jones P Jarvis JA Lewis AF Ebbutt Trials to assess equivalence: the importance of rigorous methods Br Med J 313 1996 36 39
40. PD Delmas P Vergnaud ME Arlot The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 126 1995 603 610
41. P Ammann R Rizzoli J-M Meyer J-P Bonjour Bone density and shape as determinants of bone strength in IGF-1 and/or pamidronate-treated ovariectomized rats Osteoporos Int 6 1996 219 227
42. T Chevalley R Rizzoli V Nydegger Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients Osteoporos Int 4 1994 245 252
43. JA Falch OR Odegaard M Finnanger I Matheson Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol Proc Soc Exp Biol Med 191 1987 199 204
44. JC Gallagher D Goldgar Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol A randomized controlled study Ann Intern Med 113 1990 649 655
45. C Christiansen MS Christensen P Rodbro Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis Eur J Clin Invest 11 1981 305 309
46. GF Jensen C Christiansen I Transbol Treatment of postmenopausal osteoporosis A controlled therapeutic trial comparing osestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium Clin Endocrinol. 16 1982 515 524
47. SM Ott C Chestnut Calcitriol treatment is not effective in postmenopausal osteoporosis Ann Intern Med 84 1989 267 274
48. JF Alioa A Vaswani JK Yeh Calcitriol in the treatment of postmenopausal osteoporosis Am J Med 84 1988 401 408
49. BL Riggs WM O'Fallon A Lane Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis J Bone Miner Res 9 1994 265 275
50. PJ Meunier Bone forming agents (Abstr. 42.) Osteoporos Int 6 suppl 1 1996 94
51. V Shen DW Dempster R Birchman Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol J Clin Invest 91 1993 2479 2487
52. C Ejersted TT Andreassen MHL Nilsson H Oxlund Human parathyroid hormone (1–34) increases bone formation and strength of cortical bone in aged rats Eur J Endocrinol 130 1994 201 207
53. CM Bagi MC van der Muelen S Adams D Rosen Treatment with rhlGF-1/IGFBP-3 complex improves cortical bone structure and strength in ovariectomized rats (Abstr. C276.) J Bone Miner Res 9 suppl 1 1994 S392
54. WSS Jee K Ueno YP Deng DM Woodbury The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation Calcif Tissue Int 37 1985 148 157
55. M Centrella TL McCarthy E Canalis Skeletal tissue and transforming growth factor β FASEB J 2 1988 3066 3073
56. AW Yasko JM Lane EJ Fellinger The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2) J Bone Joint Surg 74A 1992 659 670
57. GR Mundy Peptides and growth regulatory factors in bone Rheum Dis Clin North Am 20 1994 577 588
58. BL Riggs Formation-stimulating regimens other than sodium flouride Am J Med 95 suppl 5A 1993 62S 68S
59. K Overgaard MA Hansen SB Jensen C Christiansen Effect of salcatonin given intra nasally on bone mass and fracture rates in established osteoporosis: a dose-response study Br Med J 305 1992 556 561
60. NB Watts ST Harris HK Genant Intermittent cyclical etidronate therapy of post-menopausal osteoporosis New Engl J Med 323 1990 73 79
61. R Recker DB Kimmel S Hinders KM Davies Antifracture efficacy of calcium in elderly women J Bone Miner Res 9 suppl 1 1994 135
62. SJ Wimalawansa Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study Am J Med 99 1995 36 42
63. R Lindsay DM Hart H Abdalla F Al-Azzawi Inter-relationship of bone loss and its prevention, and fracture expression C Christiansen JS Johansen BJ Riis Osteoporosis 1987. International Symposium on Osteoporosis 1987 Osteopress ApS Copenhagen 508 512
64. 3 and calcium to prevent hip fractures in elderly women N Engl J Med 327 1992 1637 1642
65. KE Ensrud L Palermo DM Black Hip and calcaneal bone loss increase with advancing age: longitudinal results from the Study of Osteoporotic Fractures J Bone Miner Res 10 1995 1778 1787
66. BL Riggs SF Hodgson WM O'Fallon Effect of fluoride treatment on fracture rate in post-menopausal women with osteoporosis N Engl J Med 322 1990 802 809
67. PJ Meunier Bone forming agents (Abstr.) Osteoporos Int 6 suppl 1 1996 94